George Barker
Pooled analysis of over 18,000 participants supports benefits of finerenone across cardio-kidney-metabolic conditions
A pooled analysis of three large trials failed to demonstrate significant reductions in cardiovascul...
Money-maker or meritable: Is renal denervation out of retirement?
In a paper published in the July 2024 issue of the Journal of Hypertension, Andrew Sharp (University...
SoniVie announces advancements in its renal denervation programme
SoniVie, which has developed a novel Therapeutic Intra-Vascular Ultrasound System (TIVUS) to treat a...
